e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
Edward F. McKone, Cono Ariti, Abaigeal Jackson, Anna Zolin, Siobhán B. Carr, Annalisa Orenti, Jacqui G. van Rens, Lydie Lemonnier, Milan Macek, Ruth H. Keogh, Lutz Naehrlich
Source:
Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
Journal Issue:
September
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Edward F. McKone, Cono Ariti, Abaigeal Jackson, Anna Zolin, Siobhán B. Carr, Annalisa Orenti, Jacqui G. van Rens, Lydie Lemonnier, Milan Macek, Ruth H. Keogh, Lutz Naehrlich. Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study. Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Assessment of the association between asthma and malignancy: a population-based retrospective matched cohort study
Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases
Year: 2009
Predicting factors for sarcoidosis outcome: retrospective cohort study
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976–2013
Source: Eur Respir J , 49 (2) 1601290; DOI: 10.1183/13993003.01290-2016
Year: 2017
Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: a retrospective cohort study
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019
A contemporary survival analysis of individuals with cystic fibrosis: a cohort study
Source: Eur Respir J 2015; 45: 670-679
Year: 2015
Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study
Source: Eur Respir J, 56 (3) 2000767; 10.1183/13993003.00767-2020
Year: 2020
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients
Source: Virtual Congress 2021 – COVID - 19 around the globe
Year: 2021
Excess economic burden of comorbidities in COPD: a 15-year population-based study
Source: Eur Respir J, 50 (1) 1700393; 10.1183/13993003.00393-2017
Year: 2017
Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study
Source: Eur Respir J 2015; 45: 269-272
Year: 2015
Predicting pulmonary tuberculosis in immigrants: a retrospective cohort study
Source: ERJ Open Res, 4 (2) 00170-2017; 10.1183/23120541.00170-2017
Year: 2018
Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Mortality and prognostic factors in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Influence of statin treatment on cancer mortality in COPD patients: Retrospective observational cohort study
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020
Year: 2020
Cause-specific mortality rates in patients with COPD in primary care: a prospective analysis of the Birmingham COPD Cohort Study
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020
Exploring the association between Socioeconomic status and asthma exacerbations: a real-world prospective cohort study in Chinese adults
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study
Source: Eur Respir J, 59 (2) 2101341; 10.1183/13993003.01341-2021
Year: 2022
The effect of sex and age on the comorbidity burden of OSA: an observational analysis from a large nationwide US health claims database
Source: Eur Respir J 2016; 47: 1162-1169
Year: 2016
Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study
Source: Eur Respir J, 57 (4) 2004055; 10.1183/13993003.04055-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept